|
Name |
1-Acetyl-2-[(acetyloxy)methyl]-5-(6-amino-9h-purin-9-yl)pyrrolidine-3,4-diyl diacetate
|
Molecular Formula | C18H22N6O7 | |
IUPAC Name* |
[1-acetyl-3,4-diacetyloxy-5-(6-aminopurin-9-yl)pyrrolidin-2-yl]methyl acetate
|
|
SMILES |
CC(=O)N1C(C(C(C1N2C=NC3=C(N=CN=C32)N)OC(=O)C)OC(=O)C)COC(=O)C
|
|
InChI |
InChI=1S/C18H22N6O7/c1-8(25)24-12(5-29-9(2)26)14(30-10(3)27)15(31-11(4)28)18(24)23-7-22-13-16(19)20-6-21-17(13)23/h6-7,12,14-15,18H,5H2,1-4H3,(H2,19,20,21)
|
|
InChIKey |
BFPSTZZUEPACCS-UHFFFAOYSA-N
|
|
Synonyms |
13144-03-1; 1-acetyl-2-[(acetyloxy)methyl]-5-(6-amino-9h-purin-9-yl)pyrrolidine-3,4-diyl diacetate; NSC107178; DTXSID30296030; NSC-107178
|
|
CAS | 13144-03-1 | |
PubChem CID | 267644 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 434.4 | ALogp: | -1.1 |
HBD: | 1 | HBA: | 11 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 169.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 31 | QED Weighted: | 0.496 |
Caco-2 Permeability: | -5.979 | MDCK Permeability: | 0.00005030 |
Pgp-inhibitor: | 0.019 | Pgp-substrate: | 0.995 |
Human Intestinal Absorption (HIA): | 0.995 | 20% Bioavailability (F20%): | 0.987 |
30% Bioavailability (F30%): | 0.99 |
Blood-Brain-Barrier Penetration (BBB): | 0.56 | Plasma Protein Binding (PPB): | 15.13% |
Volume Distribution (VD): | 0.642 | Fu: | 73.70% |
CYP1A2-inhibitor: | 0.01 | CYP1A2-substrate: | 0.034 |
CYP2C19-inhibitor: | 0.072 | CYP2C19-substrate: | 0.052 |
CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.06 |
CYP2D6-inhibitor: | 0.374 | CYP2D6-substrate: | 0.026 |
CYP3A4-inhibitor: | 0.049 | CYP3A4-substrate: | 0.152 |
Clearance (CL): | 1.948 | Half-life (T1/2): | 0.878 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.963 |
Drug-inuced Liver Injury (DILI): | 0.991 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.832 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.464 | Carcinogencity: | 0.052 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.023 |
Respiratory Toxicity: | 0.901 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002667 | 0.321 | D0OL7F | 0.413 | ||||
ENC000635 | 0.317 | D09SIK | 0.400 | ||||
ENC001014 | 0.306 | D0L2UN | 0.350 | ||||
ENC002259 | 0.271 | D06ACW | 0.324 | ||||
ENC002198 | 0.252 | D06IAR | 0.317 | ||||
ENC003484 | 0.241 | D0NI0C | 0.317 | ||||
ENC005790 | 0.239 | D01BYB | 0.315 | ||||
ENC001480 | 0.237 | D0U3YU | 0.306 | ||||
ENC003278 | 0.237 | D0ML1F | 0.304 | ||||
ENC002632 | 0.234 | D0R3FP | 0.299 |